RGS13 protein may play role in suppressing allergic reactions

A protein in humans known as RGS13 suppresses allergic reactions, including the severe, life-threatening allergic reaction known as anaphylaxis. – According to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a protein in mice known as RGS13 suppresses allergic reactions, including the severe, life-threatening allergic reaction known as anaphylaxis.

$2 million of potentially harmful cosmetic eye product seized in US

Harmful cosmetic eye products may increase the risk of optic nerve damage, macular edema, uveitis leading to decreased vision and blindness. – At the request of the U.S. Food and Drug Administration, U.S. Marshals seized 12,682 applicator tubes of Age Intervention Eyelash, a product that may, in some users, lead to decreased vision. Authorities said the sales value of the seized tubes is approximately $2 million.

Nexavar approved for patients with inoperable liver cancer

Anticancer drug Nexavar raised survival period in inoperable hepatocellular carcinoma patients suffering from this kind of liver cancer. – The U.S. Food and Drug Administration has approved Nexavar (sorafenib) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar was originally approved in 2005 for the treatment of patients with advanced renal cell carcinoma, a form of kidney cancer.

Do NOT follow this link or you will be banned from the site!